PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31960922-0	2020	Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.	Doxorubicin	32-43	AKT serine/threonine kinase 1	Homo sapiens	93-96	
31960922-11	2020	RSK4 may effectively attenuate DOX resistance in BC by inhibiting the PI3K/AKT signalling pathway.	Doxorubicin	31-34	AKT serine/threonine kinase 1	Homo sapiens	75-78